CTAS

Cintas Corporation

62
Fundamentals68/ 100
Valuation41/ 100
Upside potential53/ 100
Risk potential13/ 100

CTAS's fundamentals are strong: it turned 18% of its revenue into free cash flow and revenue grew 9.5%. At 45x earnings, it's trading above its usual 39x. Analysts expect earnings growth.

CTAS Fundamentals

MetricStatus
Healthy
Strong
Strong
Healthy

CTAS's revenue, profitability, cash flow and balance sheet are all currently healthy.

CTAS PE Valuation

CHEAPFAIREXPENSIVE15x30x44x59x
CHEAPFAIREXPENSIVE15x30x44x59x
LevelPEPriceVs current
Cheap35x$179-21%
Fair39x$198-13%
Forward40x$228—
Current45x$228—
Expensive47x$239+4.9%

Historical ranges are pointers, not guarantees.

CTAS's PE is in its expensive range at 45x. If earnings grow as analysts expect, today's price would be 40x next year's earnings, in its fair range.

CTAS Forward outlook

MetricOutlook
Improving
Growth
Growth
Improving
Moderate
High

Analysts expect earnings and revenue growth for CTAS, with profitability improving.

CTAS Risk to reward

ScenarioChangePrice
Upside+15%$261.25
Downside-13%$198.04

Calculated from the latest close: $227.52 on Nov 12.

CTAS's one-year upside and downside scenarios are about the same size: +15% against −13%.

CTAS Earnings Per Share

Q4 2023: $3.45Q1 2024: $3.62Q2 2024: $3.79Q3 2024: $3.96Q4 2024: $4.15Q1 2025: $4.32Q2 2025: $4.40Q3 2025: $4.50Q4 2025: $4.62Q1 2026: $4.73Q2 2026: $4.91Q3 2026: $5.07Forward: $5.71
Q4 2023: $3.45Q1 2024: $3.62Q2 2024: $3.79Q3 2024: $3.96Q4 2024: $4.15Q1 2025: $4.32Q2 2025: $4.40Q3 2025: $4.50Q4 2025: $4.62Q1 2026: $4.73Q2 2026: $4.91Q3 2026: $5.07Forward: $5.71
QuarterTTM EPSYoY
Forward$5.71+13%
Q3 2026$5.07+13%
Q2 2026$4.91+12%
Q1 2026$4.73+9.5%
Q4 2025$4.62+11%
Q3 2025$4.50+14%
Q2 2025$4.40+16%
Q1 2025$4.32+19%
Q4 2024$4.15+20%

CTAS's earnings per share have climbed steadily: $5.07 over the past year, up 13% from the year before, and higher year over year every quarter since late 2020.

CTAS Quarterly Revenue

Q4 2023: $2.4BQ1 2024: $2.4BQ2 2024: $2.5BQ3 2024: $2.5BQ4 2024: $2.6BQ1 2025: $2.6BQ2 2025: $2.7BQ3 2025: $2.7BQ4 2025: $2.8BQ1 2026: $2.8BQ2 2026: $2.9BQ3 2026: $3B
Q4 2023: $2.4BQ1 2024: $2.4BQ2 2024: $2.5BQ3 2024: $2.5BQ4 2024: $2.6BQ1 2025: $2.6BQ2 2025: $2.7BQ3 2025: $2.7BQ4 2025: $2.8BQ1 2026: $2.8BQ2 2026: $2.9BQ3 2026: $3B
QuarterRevenueYoY
Q3 2026$3B+11%
Q2 2026$2.9B+8.9%
Q1 2026$2.8B+8.9%
Q4 2025$2.8B+9.3%
Q3 2025$2.7B+8.7%
Q2 2025$2.7B+8%
Q1 2025$2.6B+8.4%
Q4 2024$2.6B+7.8%

CTAS's revenue has grown year over year for 22 quarters in a row: $3B last quarter, up 11% from the same quarter a year ago.

CTAS Free Cash Flow

Q4 2023: $299MQ1 2024: $550MQ2 2024: $591MQ3 2024: $374MQ4 2024: $340MQ1 2025: $522MQ2 2025: $521MQ3 2025: $313MQ4 2025: $425MQ1 2026: $531MQ2 2026: $613MQ3 2026: $465M
Q4 2023: $299MQ1 2024: $550MQ2 2024: $591MQ3 2024: $374MQ4 2024: $340MQ1 2025: $522MQ2 2025: $521MQ3 2025: $313MQ4 2025: $425MQ1 2026: $531MQ2 2026: $613MQ3 2026: $465M
QuarterFree cash flowYoY
Q3 2026$464.8M+49%
Q2 2026$613.1M+18%
Q1 2026$530.6M+1.6%
Q4 2025$425M+25%
Q3 2025$312.5M-16%
Q2 2025$521.1M-12%
Q1 2025$522.1M-5.1%
Q4 2024$340M+14%

CTAS's free cash flow has been positive every quarter for seven years: $2B over the past year, up 20% from the year before.

CTAS Total Shares

Q4 2023: 413MQ1 2024: 413MQ2 2024: 413MQ3 2024: 410MQ4 2024: 411MQ1 2025: 410MQ2 2025: 410MQ3 2025: 409MQ4 2025: 406MQ1 2026: 405MQ2 2026: 406MQ3 2026: 404M
Q4 2023: 413MQ1 2024: 413MQ2 2024: 413MQ3 2024: 410MQ4 2024: 411MQ1 2025: 410MQ2 2025: 410MQ3 2025: 409MQ4 2025: 406MQ1 2026: 405MQ2 2026: 406MQ3 2026: 404M
PeriodChange %Net change
Quarterly-0.5%-1.9M shares
1 year-1.2%-5M shares
3 years-2.4%-10M shares
5 years-4.6%-19.5M shares
Available history-5.8%-25.1M shares

CTAS has 404M diluted shares, down 1.2% from a year ago, with $1B in buybacks over the past year.

CTAS Net Leverage

Q4 2023: 1.1xQ1 2024: 1.0xQ2 2024: 0.9xQ3 2024: 1.0xQ4 2024: 1.0xQ1 2025: 0.8xQ2 2025: 0.8xQ3 2025: 0.8xQ4 2025: 0.9xQ1 2026: 0.8xQ2 2026: 0.7xQ3 2026: 0.7x
Q4 2023: 1.1xQ1 2024: 1.0xQ2 2024: 0.9xQ3 2024: 1.0xQ4 2024: 1.0xQ1 2025: 0.8xQ2 2025: 0.8xQ3 2025: 0.8xQ4 2025: 0.9xQ1 2026: 0.8xQ2 2026: 0.7xQ3 2026: 0.7x
QuarterNet LeverageStatus
Q3 20260.7xVery low
Q2 20260.7xVery low
Q1 20260.8xVery low
Q4 20250.9xVery low
Q3 20250.8xVery low
Q2 20250.8xVery low
Q1 20250.8xVery low
Q4 20241.0xVery low

CTAS's net debt is less than a year of its operating earnings (EBITDA).

CTAS Weekly Momentum

MetricValueStatus
RSI68.7Neutral
Stochastic80.2Overbought

CTAS's weekly RSI is 69 (neutral) and its Stochastic is 80 (overbought).

CTAS PE vs Industrials Sector

MetricCTASSector medianRelative
PE45x24x87% above
PE %775819 pts above

CTAS is trading at 45x earnings, a 87% premium to the Industrials sector's median of 24x.

CTAS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$212.96.9% above
20 week MA$204.511% above
50 week MA$191.719% above
100 week MA$198.115% above
200 week MA$175.230% above

CTAS is in an uptrend: it's above all five of its weekly moving averages, and 30% above its 200-week average.

CTAS Yearly ROI

YearStart priceEnd priceROI
2020$67.3$84.6+26%
2021$84.6$108.8+29%
2022$108.8$114.3+5.1%
2023$114.3$150.7+32%
2024$150.7$183.4+22%
2025$183.4$191.1+4.2%
2026 YTD$191.1$227.5+19%

CTAS has finished every year since 2020 higher, and it's up 19% so far in 2026.

Give your agent the market.

Get API key